LifePoint, Inc. (LFPI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2004 | -3.26 Million USD | -239.12% |
| 2003 | 2.34 Million USD | 207.14% |
| 2002 | -2.18 Million USD | 56.32% |
| 2001 | -5.01 Million USD | 46.57% |
| 2000 | -9.38 Million USD | -95.61% |
| 1999 | -4.79 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2005 Q2 | -494.97 Thousand USD | 60.16% |
| 2005 Q3 | -2 Million USD | -304.87% |
| 2005 Q1 | -1.24 Million USD | 61.93% |
| 2004 FY | -3.26 Million USD | -239.12% |
| 2004 Q2 | -5.52 Million USD | -258.51% |
| 2004 Q1 | 3.48 Million USD | 48.54% |
| 2004 Q3 | -3.48 Million USD | 36.9% |
| 2004 Q4 | -3.26 Million USD | 6.35% |
| 2003 Q2 | -1.53 Million USD | 77.21% |
| 2003 Q3 | 733.17 Thousand USD | 147.79% |
| 2003 FY | 2.34 Million USD | 207.14% |
| 2003 Q1 | -6.73 Million USD | -207.38% |
| 2003 Q4 | 2.34 Million USD | 220.0% |
| 2002 Q4 | -2.18 Million USD | -2030.01% |
| 2002 FY | -2.18 Million USD | 56.32% |
| 2002 Q3 | -102.8 Thousand USD | 96.39% |
| 2002 Q2 | -2.84 Million USD | 31.46% |
| 2002 Q1 | -4.14 Million USD | 17.22% |
| 2001 Q3 | -4.24 Million USD | 29.37% |
| 2001 Q1 | -7.81 Million USD | 16.65% |
| 2001 Q4 | -5.01 Million USD | -18.17% |
| 2001 Q2 | -6 Million USD | 23.2% |
| 2001 FY | -5.01 Million USD | 46.57% |
| 2000 Q3 | -1.72 Million USD | 42.11% |
| 2000 Q4 | -9.38 Million USD | -443.34% |
| 2000 FY | -9.38 Million USD | -95.61% |
| 2000 Q1 | -4 Million USD | 0.0% |
| 2000 Q2 | -2.98 Million USD | 25.61% |
| 1999 FY | -4.79 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 780.528% |
| Ansell Limited | -54.99 Million USD | 94.065% |
| Ansell Limited | -55.1 Million USD | 94.076% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 91.056% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | -3005.575% |
| Psykey, Inc. | 634.59 Thousand USD | 614.349% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.272% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.271% |
| Encision Inc. | 1.29 Million USD | 352.889% |
| Golden Valley Development, Inc | - USD | Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 241.378% |
| Innovative MedTech Inc. | 1.76 Million USD | 284.958% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 166.556% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 250.972% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | -7437.458% |
| Reflect Scientific, Inc. | -1.03 Million USD | -215.271% |
| SmileDirectClub, Inc. | 778.67 Million USD | 100.419% |
| Sector 10, Inc. | 163 Thousand USD | 2102.467% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 99.218% |
| SheerVision, Inc. | 57.34 Thousand USD | 5791.505% |
| United Health Products, Inc. | 660.56 Thousand USD | 594.123% |
| Vasamed, Inc. | 22.12 Thousand USD | 14854.638% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 224.05% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 522.648% |